Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Oncolytics Biotech Inc (NQ: ONCY ) 0.9400 -0.0200 (-2.08%) Streaming Delayed Price Updated: 2:09 PM EDT, Sep 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 73,087 Open 0.9500 Bid (Size) 0.9400 (95) Ask (Size) 0.9587 (8) Prev. Close 0.9600 Today's Range 0.9300 - 0.9765 52wk Range 0.8500 - 2.300 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Extending Survival: Oncolytics Biotech's Pelareorep Shows Promise In Fighting Metastatic Breast Cancer August 14, 2024 Extending Survival: Oncolytics Biotech's Pelareorep Shows Promise In Fighting Metastatic Breast Cancer Via News Direct Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth June 20, 2024 EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GOVX),(NYSE:GSK),(NASDAQ:AZN),(NYSE:MRK) EQNX::TICKER_END Via FinancialNewsMedia Topics Death Exposures Death Performance YTD -28.79% -28.79% 1 Month -3.07% -3.07% 3 Month -7.84% -7.84% 6 Month -8.74% -8.74% 1 Year -53.92% -53.92% More News Read More Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7.5 Billion by 2033 June 20, 2024 Via FinancialNewsMedia Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth June 20, 2024 From FN Media Group LLC Via GlobeNewswire Oncolytics Biotech® Doses First Patient in Study of Pelareorep/FOLFIRINOX Combination Therapy in Pancreatic Cancer June 20, 2024 Via FinancialNewsMedia Exposures Product Safety Recap: Oncolytics Biotech Q4 Earnings March 07, 2024 Via Benzinga A Preview Of Oncolytics Biotech's Earnings March 06, 2024 Via Benzinga Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7.5 Billion by 2033 June 20, 2024 From FN Media Group LLC Via GlobeNewswire Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032 May 24, 2024 Via FinancialNewsMedia Topics Death Exposures Death Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032 May 24, 2024 From FN Media Group LLC Via GlobeNewswire Oncolytics Biotech® ASCO Abstracts Highlight Pelareorep’s Potential in Pancreatic Cancer and Immunotherapeutic Mechanism of Action May 24, 2024 Via FinancialNewsMedia ONCY Stock Earnings: Oncolytics Biotech Beats EPS for Q1 2024 May 09, 2024 Via InvestorPlace Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036 May 09, 2024 Via FinancialNewsMedia Oncolytics Biotech® Receives Regulatory Clearance to Evaluate Pelareorep in Combination with Modified FOLFIRINOX +/- an anti-PD-L1 Inhibitor in Pancreatic Cancer May 09, 2024 Via FinancialNewsMedia Biotech Innovations Paving the Way in Breast Cancer Fight April 11, 2024 Via FinancialNewsMedia Topics Death Exposures Death Product Safety Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA April 11, 2024 Via FinancialNewsMedia Exposures Product Safety Biotech’s Role in Addressing the Pancreatic Cancer Emergency March 14, 2024 Via FinancialNewsMedia ONCY Stock Earnings: Oncolytics Biotech Beats EPS for Q4 2023 March 07, 2024 Via InvestorPlace Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market – A Race Worth March 06, 2024 Via FinancialNewsMedia Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market - A Race Worth Winning March 06, 2024 Via Newsfile Oncolytics Biotech® Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCAN March 05, 2024 Via FinancialNewsMedia Earnings Scheduled For March 7, 2024 March 07, 2024 Via Benzinga Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments March 05, 2024 Via FinancialNewsMedia Cancer Immunotherapy Stocks – Tapping into Immune Systems for Next Generation Treatments February 15, 2024 Via FinancialNewsMedia Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments March 05, 2024 From FN Media Group LLC Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
